Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Terminated 2Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 2Venous Thrombosis 1Venous Thromboembolism 1Thrombosis 1Small Cell Lung Carcinoma 1Carcinoma, Small Cell 1

Interventions

Gemcitabine 34pembrolizumab 27Paclitaxel 21Cyclophosphamide 21Docetaxel 20Carboplatin 20Irinotecan 19Capecitabine 19Fluorouracil 17Bevacizumab 15Dexamethasone 14fludarabine 13Oxaliplatin 13Leucovorin 13Blood Specimen Collection 13Everolimus 12Cetuximab 12Ipilimumab 11Erlotinib Hydrochloride 11Rituximab 10Pemetrexed 10Cisplatin 10venetoclax 9Temozolomide 9Sunitinib 9Nivolumab 9Trastuzumab 8Interleukin-2 8aldesleukin 7Epoetin Alfa 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Neoplasms × bemiparin × Clear all
NCT01164046 2014-12-03

Longheva

University Medical Center Groningen

Phase 3 Terminated
56 enrolled
Classical hematology

Neoplasms, Venous Thrombosis, Venous Thromboembolism

NCT00311896 2012-06-08

Efficacy & Safety of Prophylaxis With Bemiparin in Cancer Patients With a Central Venous Catheter (BECAT)

Clinica Universidad de Navarra, Universidad de Navarra

Phase 3 Terminated
402 enrolled

Neoplasms, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡